Literature DB >> 22224623

Prevalence of anti-dengue immunoglobulin G antibodies among American Red Cross blood donors in Puerto Rico, 2006.

Hamish Mohammed1, Kay M Tomashek, Susan L Stramer, Elizabeth Hunsperger.   

Abstract

BACKGROUND: Dengue is endemic in Puerto Rico and causes periodic outbreaks involving thousands of persons. Seroprevalence studies among blood donors can provide useful data on the immune status of the adult population. The objective of this study was to determine the prevalence of anti-dengue immunoglobulin (Ig)G antibodies in a random sample of blood donors to the American Red Cross (ARC) in Puerto Rico. STUDY DESIGN AND METHODS: Three-hundred randomly selected blood donations collected by the ARC from February 1 to March 31, 2006, were tested using an anti-dengue IgG enzyme-linked immunosorbent assay. One-third of the positive specimens were randomly selected and tested by a microneutralization test (MNT) to determine the serotypes of previous dengue infections.
RESULTS: Most (84%) blood donors were male, and the mean age was 44.6 years (range, 18-80 years). The prevalence (95% confidence interval) of anti-dengue IgG antibodies was 92% (89%-95%). Of the 92 specimens tested by the MNT, reactivity to all four dengue serotypes was observed and 96% were secondary infections. The predominant serotype with the highest neutralization titers, as identified by at least a fourfold higher titer compared to any other serotype tested, was identified in 32 specimens; the most common predominant serotypes identified by the MNT were DENV-3 and DENV-2 (63%). Recent infection with DENV-1 was detected but, in 2005, routine surveillance did not detect any cases of this serotype.
CONCLUSION: Supplementary serologic testing of donated blood can potentially provide information on the silent circulation or introduction of dengue serotypes.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22224623     DOI: 10.1111/j.1537-2995.2011.03492.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  14 in total

1.  Persistence of Zika Virus in Body Fluids - Final Report.

Authors:  Gabriela Paz-Bailey; Eli S Rosenberg; Kate Doyle; Jorge Munoz-Jordan; Gilberto A Santiago; Liore Klein; Janice Perez-Padilla; Freddy A Medina; Stephen H Waterman; Carlos Garcia Gubern; Luisa I Alvarado; Tyler M Sharp
Journal:  N Engl J Med       Date:  2017-02-14       Impact factor: 91.245

2.  Optimization of the cutoff value for a commercial anti-dengue virus IgG immunoassay.

Authors:  Karla M Marrero-Santos; Manuela Beltrán; Jessica Carrión-Lebrón; Carolina Sanchez-Vegas; Davidson H Hamer; Elizabeth D Barnett; Luis M Santiago; Elizabeth A Hunsperger
Journal:  Clin Vaccine Immunol       Date:  2013-01-09

3.  Multiplexed Biomarker Panels Discriminate Zika and Dengue Virus Infection in Humans.

Authors:  Guang Song; Hee-Sool Rho; Jianbo Pan; Pedro Ramos; Ki-Jun Yoon; Freddy A Medina; Emily M Lee; Daniel Eichinger; Guo-Li Ming; Jorge L Muñoz-Jordan; Hengli Tang; Ignacio Pino; Hongjun Song; Jiang Qian; Heng Zhu
Journal:  Mol Cell Proteomics       Date:  2017-11-15       Impact factor: 5.911

4.  Risk factors for infection with chikungunya and Zika viruses in southern Puerto Rico: A community-based cross-sectional seroprevalence survey.

Authors:  Laura E Adams; Liliana Sánchez-González; Dania M Rodriguez; Kyle Ryff; Chelsea Major; Olga Lorenzi; Mark Delorey; Freddy A Medina; Jorge L Muñoz-Jordán; Grayson Brown; Marianyoly Ortiz; Stephen H Waterman; Vanessa Rivera-Amill; Gabriela Paz-Bailey
Journal:  PLoS Negl Trop Dis       Date:  2022-06-13

Review 5.  Prevalence of Chikungunya, Dengue and Zika viruses in blood donors: a systematic literature review and meta-analysis.

Authors:  Ángel Giménez-Richarte; Mabel Ortiz de Salazar; Cristina Arbona; María P Giménez-Richarte; Miriam Collado; Pedro L Fernández; Francisco Quiles; Carlos Clavijo; Pascual Marco; Jose-Manuel Ramos-Rincon
Journal:  Blood Transfus       Date:  2021-09-22       Impact factor: 5.752

6.  Enhanced West Nile virus surveillance in a dengue-endemic area--Puerto Rico, 2007.

Authors:  Jomil M Torres-Aponte; Richard R Luce; Elizabeth Hunsperger; Jorge L Muñoz-Jordan; Manuela Beltrán; Edgardo Vergne; D Fermín Argüello; Enid J García; Wellington Sun; Kay M Tomashek
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

7.  Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?

Authors:  Marion C Lanteri; Michael P Busch
Journal:  Transfusion       Date:  2012-08       Impact factor: 3.157

8.  Dengue seroprevalence in the French West Indies: a prospective study in adult blood donors.

Authors:  Maïna L'Azou; Janick Jean-Marie; Maël Bessaud; André Cabié; Raymond Césaire; Xavier de Lamballerie; Rémi Courbil; Pascale Richard
Journal:  Am J Trop Med Hyg       Date:  2015-04-06       Impact factor: 2.345

9.  Distribution of Dengue Virus Types 1 and 4 in Blood Components from Infected Blood Donors from Puerto Rico.

Authors:  Germán Añez; Daniel A R Heisey; Caren Chancey; Rafaelle C G Fares; Luz M Espina; Kátia P R Souza; Andréa Teixeira-Carvalho; David E Krysztof; Gregory A Foster; Susan L Stramer; Maria Rios
Journal:  PLoS Negl Trop Dis       Date:  2016-02-12

10.  Immunologic hypo- or non-responder in natural dengue virus infection.

Authors:  Guey Chuen Perng; Kulkanya Chokephaibulkit
Journal:  J Biomed Sci       Date:  2013-05-31       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.